EGFR & ALK Inhibitors for Mutated Lung Cancer Tumors
Overview
NA
Target Audience
NA
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Miguel A. Villalona-Calero, MD, FACP, FAAAS
Date of Release
May 14th, 2025
-1762274923981.webp&w=3840&q=75)
-1760723320622.webp&w=3840&q=75)